Trial intelligence / Profile preview

TJ-116 bukuryoingohangekobokuto for anxiety and postoperative water brash in esophageal cancer surgery

jRCTs021190001Completed

Sponsor
Tsumura & Co.
Start
May 2019
Countries
1
01

Overview

Open-label, single-arm trial of bukuryoingohangekobokuto in esophageal cancer, anxiety disorder and Water brash, sponsored by Tsumura & Co. Primary endpoint: Symptoms of feeling, anxiety, water brash. Started May 2019; status: completed.

02

Drugs

bukuryoingohangekobokuto
03

Conditions

esophageal canceranxiety disorderWater brash

Beyond the preview

Go deeper on jRCTs021190001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs021190001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call